IFNG and neoplasm: S. Typhimurium BRD509 secreting IFN-γ showed selective growth in B16F10 mouse melanoma when administered by three routes of administration (intravenous, oral, and subcutaneous), and subcutaneous treatment significantly inhibited tumor growth.